ADAPTIN BIO, INC.
ADAPTIN BIO, INC.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | |||||
Assets Current | |||||||||||||||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | - | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Prepaid Expense Current | - | 0 | - | - | 0 | 0 | - | - | - | - | - | - | |||||
Assets Current | 1 | 1 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 1 | 1 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Noncurrent | |||||||||||||||||
Deferred Costs | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Liabilities Current | |||||||||||||||||
Notes Payable Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable Current | 2 | 1 | 2 | 1 | 1 | 0 | 1 | - | - | - | - | - | |||||
Other Notes Payable Current | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | |||||
Convertible Debt Current | - | - | - | - | - | - | 1 | - | - | - | - | - | |||||
Derivative Liabilities Current | - | - | - | - | - | - | 1 | - | - | - | - | - | |||||
Interest Payable Current | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Liabilities Current | 3 | 2 | 2 | 2 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 3 | 2 | 2 | 2 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 10 | 9 | 8 | 7 | 7 | 6 | 0 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -12 | -10 | -9 | -8 | -6 | -5 | -4 | -0 | -0 | -0 | -0 | -0 | |||||
Stockholders Equity | -2 | -2 | -1 | -1 | 0 | 2 | -4 | -3 | -2 | -1 | -0 | -0 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Common Stock Shares Issued | 9 | 9 | 9 | 8 | 8 | 8 | 3 | 5 | 5 | 5 | 5 | 5 | |||||
Shares Outstanding | 9 | 9 | 9 | 8 | 8 | 8 | 3 | 5 | 5 | 5 | 5 | 5 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
ADAPTIN BIO, INC. (APTN) — SEC Financial Statements & Analysis
ADAPTIN BIO, INC. (APTN) is a biological products, (no diagnostic substances) company, incorporated in DE. ADAPTIN BIO, INC. trades on OTC as: APTN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ADAPTIN BIO, INC. reported a Debt-to-Equity ratio of -1.59x, a Price-to-Book (P/B) ratio of -33.05x (TTM), at a market cap of $55.04M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.59x
- P/B TTM
- -33.05x
- Market Cap
- $55.04M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ADAPTIN BIO, INC. in?
ADAPTIN BIO, INC. (APTN) operates in the Biological Products, (No Diagnostic Substances) industry.
What is APTN's market cap?
ADAPTIN BIO, INC. (APTN) has a market capitalization of $55.04M as of 2026-06-30.
What exchange does APTN trade on?
ADAPTIN BIO, INC. (APTN) trades on the OTC.
Where is ADAPTIN BIO, INC. incorporated?
ADAPTIN BIO, INC. is incorporated in DE.